The Effect of Intrahepatic and Intrasplenic Administration of Mesenchymal Stem Cell to Liver Function and Degree of Liver Fibrosis in Common Bile Duct Ligation Model in Rabbit

jpedsurg.org

Mesenchymal stem cells (MSC) is a promising alternative method in liver cirrhosis management. Several administration routes of MSC have been studied, but few studies compared one to another. The purpose of this study is to compare the intrahepatic and intrasplenic route of MSC administration in terms of liver function and degree of liver fibrosis in the bile duct ligation model in rabbits.

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Dec 2023 · 1 min read

In brief

This experimental study compares intrahepatic versus intrasplenic delivery of mesenchymal stem cells in a rabbit model of bile duct obstruction-induced liver fibrosis. The research evaluates which administration route more effectively improves liver function and reduces fibrosis severity.

Mesenchymal stem cells show promise as an alternative treatment for liver cirrhosis management.
Multiple MSC administration routes exist, but comparative efficacy data between routes remains limited.
Intrahepatic and intrasplenic routes are being compared for MSC delivery in bile duct ligation models.
Study endpoints include liver function parameters and quantitative assessment of liver fibrosis degree.
Rabbit bile duct ligation model serves as translational research platform for cirrhosis therapeutics.

Written by the GCMD Library team from the article.

Read it at the source ↗